β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease

Molecular Genetics and Metabolism

Volumn 104, Issue 1-2, 2011, Pages 149-152

  Moraitou, Marina ^a   Hadjigeorgiou, Georgios ^b   Monopolis, Ioannis ^a   Dardiotis, Efthimios ^b   Bozi, Maria ^c   Vassilatis, Demitris ^d   Vilageliu, Lluisa ^e   Grinberg, Daniel ^e   Xiromerisiou, Georgia ^b   Stefanis, Leonidas ^c,d   Michelakakis, Helen ^a  

^a Institute of Child Health   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^e UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Glucocerebrosidase gene mutations; Parkinson's disease

Indexed keywords

BETA GLUCOCEREBROSIDASE; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; ETHNICITY; FEMALE; GAUCHER DISEASE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC RISK; GEOGRAPHY; GREECE; HEREDITY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; GLUCOSYLCERAMIDASE; GREECE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; RESTRICTION MAPPING;

EID: 80052529044     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2011.06.015     Document Type: Article

References (28)

1. Beutler E., Grabowski G.A. Gaucher disease. The Metabolic and Molecular Basis of Inherited Disease 2001, 3635-3668. McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
2. Beutler E., Gelbart T., Scott C.R. Hematologically important mutations: Gaucher disease. Blood Cells Mol. Dis. 2005, 35:355-364.
3. Hruska K.S., LaMarca M.E., Scott C.R., Sindransky C. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum. Mutat. 2008, 29:567-583.
4. Biegstraaten M., van Schaik I.N., Aerts J.M., Hollak C.E. Non-neuronopathic Gaucher disease reconsidered. Prevalence of neuronological manifestations in a Ducth cohort of type 1 Gaucher disease patients and a systematic review of the literature. J. Inher. Metab. Dis. 2008, 31:337-349.
5. Capablo J.I., Saenz de Cabezon A., Fraile J., Alfonso P., Pocovi M., Giraldo P. Neurological evaluation of patients with Gaucher disease diagnosed as type 1. J. Neurol. Neurosurg. Psychiatry 2008, 79:219-222.
6. Lee A.J., Hardy J., Revesz T. Parkinson's disease. Lancet 2009, 373:2055-2066.
7. Lesage S., Brice A. Parkinson's disease: form monogenic forms to genetic susceptibility factors. Hum. Molec. Genet. 2009, 18:R48-R59.
8. DiMonte D.A., Lavasani M., Mannivug-Bog A.B. Enviromental factors in Parkinson's disease. Neuro. Toxicol. 2002, 23:487-502.
9. Ruiperez V., Darios G., Davletov B. Alpha-synuclein, lipids and Parkinson's disease. Prog. Lip. Res. 2010, 49:420-428.
10. Sidransky E., Nalls M.A., Aasly J.O., Aharon-Peretz J., Annesi G., Barbosa E.R., Bar-Shira A., Berg D., Bras J., Brice A., Chen C.M., Clark L.N., Condroyer C., De Marco E.V., Düzz A., Eblan M.J., Fahn S., Farrer M.J., Fung H.C., Gan-Or Z., Gasser T., Gershoni-Baruch R., Giladi N., Griffith A., Gurevich T., Januario C., Kropp P., Lang A.E., Lee-Chen G.J., Lessage S., Marder K., Mata I.F., Mirelman A., Mitsui J., Mizuta I., Nicoletti G., Oliveira C., Ottman R., Orr-Urtreger A., Pereira L.V., Quattrone A., Rogaeva E., Rolfs A., Rosenbaum H., Rozenberg R., Samii A., Samaddar T., Schulte C., Sharma M., Singleton A., Spitz M., Tan E.K., Tayebi N., Toda T., Troiano A.R., Tsuji S., Wittstock M., Wolfsberg T.G., Wu Y.R., Zabetian C.R., Zhao Y., Ziegler S.G. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. New Engl. J. Med. 2009, 361:1651-1661.
11. DePaolo J., Ozlem Goker-Alpan B.A., Samaddar T., Lopez G., Sidransky E. The association between mutations in the lysosomal protein glucocerebrosidase and Parkinsonism. Mov. Disord. 2009, 24:1575-1578.
12. Rosenbloom B., Balwani M., Bronstein J.M., Kolodny E., Sathe S., Gwosdow A.R., Taylor J.S., Cole J.A., Zimran A., Weinreb N.J. The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry. Blood Cells Mol. Dis. 2011, 46:95-102.
13. Wong K., Sidransky E., Vernia A., Mixon T., Sandberg G.D., Wakefield L.K., Morrison A., Lwin A., Colegial C., Allman J.M., Schiffmann R. Neuropathology provides clues to the pathophysiology of Gaucher disease. Molec. Genet. Metab. 2004, 82:192-207.
14. Goker-Alpan O., Stubblefield B.K., Giasson B.I., Sidransky E. Glucocerebrosidase is present in a-synuclein inclusions in Lewy body disorders. Acta Neuropathol. 2010, 120:641-649.
15. Toft M., Pielsticker L., Ross O.A., Aasly J.O., Farrer M.J. Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population. Neurology 2006, 66:415-417.
16. Kalinderi K., Bostantjopoulou S., Paisan-Ruiz C., Katsarou Z., Hardy J., Fidani L. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece. Neurosci. Lett. 2009, 452:87-89.
17. Gan-Or Z., Giladi N., Rozovski V., Shifrin C., Rosner S., Gurevich T., Bar-Shira A., Orr-Urtreger A. Genotype phenotype correlations between GBA mutations and Parkinson disease risk and onset. Neurology 2008, 70:2277-2283.
18. Nagarkatti R., Rao C.B., Rishi J.P., Chetiwal R., Shandilya V., Vijayam V., Kumar R., Pemde H.K., Sharma S.K., Sharma S., Singh A.B., Gangal S.V., Ghosh B. Association of IFNG gene polymorphism with asthma in the Indian population. J. Allergy Clin. Immunol. 2002, 110:410-412.
19. Santamaria R., Michelakakis H., Moraitou M., Dimitriou E., Dominissini S., Grossi S., Sanchez-Ollé G., Chabas A., Pittis M.G., Filocamo M., Vilageliu L., Grinberg D. Haplotype analysis suggests a single Balkan origin for the Gaucher disease [D409H:H255Q] double mutant allele. Hum. Mutat. 2008, 29:E58-E67.
20. Michelakakis H., Moraitou M., Dimitriou E., Santamaria R., Sanchez G., Gort L., Chabas A., Grinberg D., Dassopoulou M., Fotopoulos S., Vilageliu L. Homozygosity for the double D409H:H255Q allele in type II Gaucher disease. J. Inher. Metab. Dis. 2006, 29:591.
21. Vithayathil J., Gibney G., Baxevanis A.D., Stubblefield B.K., Sidransky E., Tayebi N. Glucocerebrosidase mutation H255Q appears to be exclusively in cis with D409H: structural implications. Clin. Genet. 2009, 75:503-504.
22. Walker J.M., Lwin A., Tayebi N., LaMarca M.E., Orvisky E., Sidransky E. Glucocerebrosidase mutation T369M appears to be another polymorphism. Clin. Genet. 2003, 63:237-238.
23. Neumann J., Bras J., Deas E., O'Sullivan S.S., Parkkinen L., Lachmann R.H., Li A., Holton J., Guerreiro R., Paudel R., Segarane B., Singleton A., Lees A., Hardy J., Houlden H., Revesz T., Wood N.W. Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain 2009, 132:1783-1794.
24. Dimitriou E., Moraitou M., Troungos C., Schulpis K., Michelakakis H. Gaucher disease: frequency of the N370S mutation in the Greek population. Clin. Genet. 2010, 78:195-196.
25. Lesage S., Anheim M., Condoyer C., Pollak P., Durif F., Dupuits C., Yiallet F., Lohmann E., Corvol J.C., Honore A., Rivand S., Vidailhet M., Dürr A., Brice A.- Hum. Molec. Genet. 2011, 20:202-210. for the French Parkinson's Disease Genetics Study Group Large-scale screening of the Gaucher's disease related glucocerebrosidase gene in Europeans with Parkinson's disease.
26. Ron I., Rapaport D., Horowitz M. Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease. Hum. Mol. Genet. 2010, 19:3771-3781.
27. Xu Y.H., Sun Y., Ran H., Quinn B., Witte D., Grabowski G.A. Accumulation and distribution of a-synuclein and ubiquitin in the CNS of Gaucher disease mouse models. Mol. Genet. Metab. 2011, 102:436-447.
28. Hemsley K.M., Hopwood J.J. Lessons learnt from animal moderls: pathophysiology of neuronopathic lysosomal storage disorders. J. Inherit. Metab. Dis. 2010, 33:363-371.